|
1) Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958; 258: 1123-42
|
|
|
|
2) Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002; 166: 215-35
|
|
|
|
|
3) Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med. 2003; 349: 2527-39
|
|
|
|
|
|
4) Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 1994; 264: 713-16
|
|
|
|
|
|
5) Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994; 91: 5592-96
|
|
|
|
|
|
6) Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999; 190: 875-80
|
|
|
|
|
|
7) Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000; 162(2 Pt 1): 658-62
|
|
|
|
|
|
8) Sakagami T, Beck D, Suzuki T, et al. Pulmonary alveolar proteinosis (PAP) reproduced in non-human primates. Am J Respir Crit Care Med. 2009; 179: A3030
|
|
|
|
|
|
9) Ramirez-R J. Pulmonary alveolar proteinosis: Treatment by massive bronchopulmonary lavage. Arch Int Med. 1967; 119: 147-56
|
|
|
|
|
|
10) Ben-Abraham R, Greenfeld A, Rozenman J, et al. Pulmonary alveolar proteinosis: step-by-step perioperative care of whole lung lavage procedure. Heart Lung. 2002; 31: 43-9
|
|
|
|
|
|
11) Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004; 23: 526-31
|
|
|
|
|
|
12) 一和多俊男, 時田心吾, 相馬亮介, 他. 肺胞蛋白症に対する片側全肺洗浄の経験と洗浄手順を選択するためのアルゴリズムについて. 日呼吸会誌. 2009; 47: 185-90
|
|
|
|
|
13) Seymour JF, Dunn AR, Vincent JM, et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med. 1996; 335: 1924-5
|
|
|
|
|
|
14) Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med. 2001; 163: 524-31
|
|
|
|
|
|
15) Kavuru MS, Sullivan EJ, Piccin R, et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000; 161(4 Pt 1): 1143-8
|
|
|
|
|
|
16) Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 2006; 130: 227-37
|
|
|
|
|
|
17) Anderson PM, Markovic SN, Sloan JA, et al. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung meta-stases. Clin Cancer Res. 1999; 5: 2316-23
|
|
|
|
|
|
18) Wylam ME, Ten RM, Katzmann JA, et al. Aerosolized GM-CSF improves pulmonary function in idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000; 161: A889
|
|
|
|
|
|
19) Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2005; 171: 1142-9
|
|
|
|
|
|
20) Wylam ME, Ten R, Prakash UB, et al. Aerosol granulocyte─macrophage colony stimulating factor for pulmonary alveolar proteinosis. Eur Respir J. 2006; 27: 585-93
|
|
|
|
|
|
21) Kavuru MS, Bonfield TL, Thomassen MJ. Plasmapheresis, GM-CSF, and alveolar proteino-sis. Am J Respir Crit Care Med. 2003; 167: 1036
|
|
|
|
|
|
22) Luisetti M, Rodi G, Perotti C, et al. Plasma-pheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J. 2009; 33: 1220-2
|
|
|
|
|
|
23) Borie R, Debray MP, Laine C, et al. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J. 2009; 33: 1503-6
|
|
|
|
|
|
24) Parker LA, Novotny DB. Recurrent alveolar proteinosis following double lung transplantation. Chest. 1997; 111: 1457-8
|
|
|
|
|
|
25) Diaz JP, Manresa Presas F, Benasco C, et al. Response to surfactant activator (ambroxol) in alveolar proteinosis. Lancet. 1984; 1: 1023
|
|
|
|
|
|
26) Hashizume T. Pulmonary alveolar proteinosis successfully treated with ambroxol. Intern Med. 2002; 41: 1175-8
|
|
|
|
|
27) Suzuki T, Sakagami T, Rubin BK, et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008; 205: 2703-10
|
|
|
|
|